| ORIGINAL ARTICLE |
|
| Year : 2019 | Volume
: 24
| Issue : 1 | Page : 36-43 |
|
|
Social and clinical correlates of stimulant use disorder (mephedrone) in a tertiary mental health setting in Mumbai: A pilot exploratory study
DU Bharath1, Poornima S Rao1, Vinayak Pandurang Kale1, Sunil Kumar Panigrahi2, Murali Krishna3, Steven Jones4, Sumanth Mallikarjuna Majgi5
1 Departments of Psychiatry, Grant Government Medical College, Mumbai, Maharashtra, India
2 Departments of Community Medicine, Grant Government Medical College, Mumbai, Maharashtra, India
3 Department of Psychiatry, Foundation for Research and Advocacy in Mental Health (FRAMe), Mysore, Karnataka, India
4 Department of Mental Health, Post Graduate Medical School, University of Chester, Chester, England
5 Department of Community Medicine, Mysore Medical College and Research Institute, Mysore, Karnataka, India
Correspondence Address:
Poornima S Rao
Grant Government Medical College, Mumbai - 400 008, Maharashtra
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jmhhb.jmhhb_40_19
|
|
|
Introduction: Increasing mephedrone use is a major public health concern in India. There are limited data on sociodemographic determinants and psychiatric comorbidity associated with stimulant use disorder (mephedrone) (SUD-M) from India. Aim: The primary objective of this study was to report the clinical and social correlates of SUD-M among those presenting to specialist mental health services in Mumbai, India. Methods: Patients with SUD-M were recruited from a clinical setting. Standardized culturally validated assessments were carried out to obtain information about sociodemographics and mental health: comorbid psychopathology Brief Psychiatric Rating Scale, Hamilton Anxiety Rating Scale, Hamilton Depression Rating Scale, and Minnesota Multiphasic Personality Inventory-2 for personality traits and a clinical assessment for diagnosis of mental disorder using DSM-5. Results: SUD-M was more common among young men from the low socioeconomic position. The most common reasons for choosing mephedrone over other substances were better high from the drug and peer pressure. There were no associations between sociodemographic factors with the severity of SUD-M. Around 40% of the patients with SUD-M had psychiatric comorbidity. Psychotic disorders and anxiety symptoms were most common. Family history of substance use, comorbid substance use, and comorbid psychiatric disorders were directly related to the severity of SUD-M. Conclusions: This was a cross-sectional study with a relatively smaller sample size of self-nominating participants limiting the generalizability of findings to a wider population. Therapeutic implication of this finding is that prompt attention and treatment of the comorbid psychiatric disorder is essential while treating patients with SUD-M. Further population-based studies are recommended for a better understanding of the burden of SUD-M.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
